verified SJR 0,15 · Q4 • database Scopus / SJR indexed

United Arab Emirates · Bentham Science Publishers

workspace_premium Q4 — Endocrinology lock Subscription

Current Signal Transduction Therapy

Current Signal Transduction Therapy is a journal indexed in SJR in Endocrinology and Pharmacology (medical) with an H index of 22. It has an SJR impact factor of 0,15 and it has a best quartile of Q4. It has an SJR impact factor of 0,15.

ISSN: 1574-3624

Publisher: Bentham Science Publishers

Category: Endocrinology

Indexation: verifiedScopus / SJR

open_in_new Portal NPD menu_book Guidelines NPD

schedule CountryOfPapers database fields

SJR Impact Factor trending_up

0,15 Q4

H-index 22

Acceptance rate pie_chart

42%

Source Acceptance_Rate

Time to publication hourglass_top

NPD

Field NPD

Publication cost (APC) payments

NPD Subscription

Non-OA path NPD

Metrics

Scimago and CountryOfPapers database fields

Scopus / SJR

SJR Impact

0,15

H-index

Docs (year)

Docs 3y

Total refs

1580

Cites 3y

Citable 3y

Cites/Doc 2y

0.68

Ref/Doc

87.78

Immediate OA

—

Embargoed OA

NPD

Non OA / Submission

—

shield Researcher voice

Name good journals. Call out predatory ones.

Share what peer review, fees, and timelines were really like. Praise fair editors. Flag APC traps, fake metrics, or spam solicitations — with facts from your submission.

Fair & fast peer review Clear APC / no surprise fees Suspected predatory Fake impact claims

rate_review Write an honest review

Researcher reviews

sentiment_dissatisfied No reviews yet — be the first to share an honest experience.

Publication speed *

Review quality *

Edition and editorial team *

Institutional email or ORCID * * Only to validate authenticity — identity is not shown publicly.

Best articles by citations

Dasatinib in the Treatment of Chronic Myeloid Leukemia

YB-1 Protein and Multidrug Resistance of Tumor Cells

Hepatocyte Growth Factor (HGF), an Endogenous Pulmotrophic Regulator, for the Rescue of Acute and Chronic Lung Diseases

Harmine Induces Gastric Cancer Cell Apoptosis through the ROSmediated PI3K/AKT Signaling Pathway

Glucocorticoid-induced Tumor Necrosis Factor Receptor Ligand Aggravates Lipopolysaccharide-induced Inflammation by Down-regulating the Programmed Death Ligand in Kupffer Cells

FBP1, A Tumor Suppressor and Negative Regulator of Glycolysis, was Epigenetically Silenced in Pancreatic Cancer

Estrogen Receptor-Positive and Estrogen Receptor-Negative Human Breast Cancer Cells: Regulation of Expression of Cancer-Related Genes by Estradiol and Tamoxifen

Enhanced Neuroprotection of Ischemic Stroke Based on Liposomal Drug Delivery System Loading a Novel Uncoupler of Ischemia-induced nNOSPSD- 95

Enhanced Free Radical Status of Cancer Cells Success and Failure of Prooxidant/Antioxidant Treatment

Editorial [Hot Topic: Hepatocyte Growth Factor and Its Signalling, New Horizons in Medicine and Therapies (Guest Editors: Wen G. Jiang and Kunio Matsumoto)]

EDITORIAL (Hot Topic: "Signal Transduction and Response to Anti-Cancer Therapy")

EDITORIAL

SHOW MORE ARTICLES

Dystroglycan, A Multifunctional Adaptor Protein for Signal Transduction and A Potential Therapeutic Target

A Comparison of Digital Image Interpolators for Intra-Frame Compression of Real-Time HD Color Videos

Current Strategies to Improve the Efficacy and the Delivery of Nucleic Acid Based Drugs

Concepts of Egr-1 Activation -A Hub for Signal Transduction Cascades

Clinical Significance of Mesothelin in Pancreatic Cancer

Chemoresistance of Cancer Cells: Oncogenic Mutation of the p53 Tumor Suppressor Gene

Carotenoids as Modulators of Intracellular Signaling Pathways

Bladder Cancer and Stem Cells

Black Hole Attack Detection In Healthcare Wireless Sensor Networks Using Independent Component Analysis Machine Learning Technique

Biology and Impact of Signal Transducers and Activators of Transcription and Their Regulators as Targets in Cancer Therapy

Balance Between S6K-S6 and 4E-BP1 Depends on ERK Activity in Developing Neurons

Automated Brain Tumor Segmentation from Magnetic Resonance Images using Morphometric Algorithms

FAQs

Current Signal Transduction Therapy has an SJR of 0,15 (best quartile Q4) in the CountryOfPapers database.

Immediate OA APC is not available (NPD).

The acceptance rate recorded for Current Signal Transduction Therapy is 42%.

Current Signal Transduction Therapy

Metrics

Name good journals. Call out predatory ones.

Researcher reviews

Best articles by citations

FAQs

What is the SJR of Current Signal Transduction Therapy?

What is the APC / publication cost?

What is the acceptance rate?